Excited today to share Ph1b data showing BGE-105's protective effect on muscle atrophy! Target identified from our human data platform, with broad potential to address many diseases of muscle aging.
This was a huge effort by our whole team @bioagelabs - congrats all!
Yesterday, we announced positive Phase 1b topline data showing that BGE-105 prevented muscle atrophy in older people.
BioAge advisor Bill Evans, the first to describe sarcopenia, believes BGE-105 has potential as a therapy for diseases of muscle aging:
https://t.co/yFMUZoWhiq
BioAge is pleased to announce positive topline Phase 1b data showing that our apelin receptor agonist BGE-105 prevented muscle atrophy in healthy volunteers aged ≥65 years on bed rest.
https://t.co/yFMUZpeqwy
Keep reading to learn why we’re so excited about this.
(🧵 1/6)
The killifish or nothobranchius furzeri is a model present in our laboratory @RestoreInstitut @Inserm@INSPIREPlatfor1. If you are interested, do not hesitate to come and discuss with our experts of this model https://t.co/iruQUlogtY.
HelloTWT. Our team working on the relationship between adipose tissue dysfunction and insulin resistance in obesity and type 2 diabetes is now on Twitter @IRADIPOLC3M
Fantastic lecture from Berenice @BBParis1984 to M2 students « physiopathologie » for UE aging from @Univ_Toulouse @RestoreInstitut. Thank you Berenice for the time you spent with us tonight live from Los Angeles on thanks giving day...
Le Dr Fabien Pillard, médecin spécialiste de la Clinique Universitaire du Sport du CHU de Toulouse, s'est exprimé au JT de France 2 du 17 Février 2021 sur les bienfaits de la marche.
Découvrez le reportage à 26 minutes 50 en suivant le lien : https://t.co/chbp1PjxlF
Almost 100 scientist from Inspire academic team and Pierre Fabre research center are meeting today Mostly online to share first results from the inspire platform for geroscience
Three-dimensional facial-image analysis to predict heterogeneity of the human ageing rate and the impact of lifestyle | Nature Metabolism https://t.co/v7q1dtMRRy